1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 4,228 | 4,452 | 24.09. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | NanoViricides, Inc.: Significantly Improved Safety Profile and Metabolism of Remdesivir Observed Due to Encapsulation in NanoViricides Drug Candidate Enabling Potential Highly Effective Pan-Coronavirus Antiviral Drug | 278 | PR Newswire | SHELTON, Conn., Sept. 22, 2021 /PRNewswire/ -- NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel... ► Artikel lesen | |
| Mi | XFRA NV3P: WIEDERAUFNAHME/RESUMPTION | 163 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| Di | NNVC Stock: What Is Going on With Red-Hot NanoViricides Today? | 11 | InvestorPlace | ||
| NANOVIRICIDES Aktie jetzt für 0€ handeln | |||||
| Di | What Is a 'News Pending' Halt? What to Know as NNVC Stock Captivates Investors | 2 | InvestorPlace | ||
| Di | NanoViricides surges 60% on COVID remdesivir encapsulation data | 8 | Seeking Alpha | ||
| Di | NNVC, RWLK and INDI among mid-day movers | 32 | Seeking Alpha | ||
| Di | ReWalk Robotics, NanoViricides leads healthcare gainers; Edesa Biotech, Verrica Pharmaceuticals among major losers | 55 | Seeking Alpha | ||
| Di | XFRA NV3P: AUSSETZUNG/SUSPENSION | 217 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNANOVIRICIDES NEW... ► Artikel lesen | |
| Di | EXCLUSIVE: NanoViricides' Remdesivir-Encapsulated COVID-19 Therapy Shows Encouraging Preclinical Safety Profile | 32 | Benzinga.com | ||
| 15.09. | YY, NNVC and REKR among mid-day movers | 2 | Seeking Alpha | ||
| 14.09. | NanoViricides Completes Licensing for Coronavirus Field which Includes Current COVID-19 Drug Development | 10 | Benzinga.com | ||
| 14.09. | EXCLUSIVE: NanoViricides Beefs Up Its COVID-19 Pipeline With TheraCour Licensing Pact | 4 | Benzinga.com | ||
| 22.06. | NanoViricides Review: What you Need to Know About the Company | 15 | Benzinga.com | ||
| 17.05. | NanoViricides, Inc.: NanoViricides Has Filed Quarterly Report for Period Ending March 31, 2021 - Has Sufficient Cash, Coronavirus Drug Candidate Moving Towards IND | 1.291 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / May 17, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines... ► Artikel lesen | |
| 14.05. | NANOVIRICIDES, INC. - 10-Q, Quaterly Report | 3 | SEC Filings | ||
| 04.05. | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 04.05.2021 | 2.319 | Xetra Newsboard | The following instruments on XETRA do have their first trading 04.05.2021 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag am 04.05.2021
Aktien
1 NO0010895568 Airthings AS
2 ES0105148003... ► Artikel lesen | |
| 09.03. | NanoViricides, Inc. Pan-coronavirus COVID-19 Drug Candidates Are Highly Effective in Pre-clinical Animal Studies in Support of FDA Pre-IND Application | 1.242 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / March 9, 2021 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines... ► Artikel lesen | |
| 02.03. | NanoViricides, Inc. Pan-coronavirus Clinical Drug Candidates for the Treatment of COVID-19 Are Highly Effective in Pre-clinical Cell Culture Studies Performed in Preparation of FDA Pre-IND Application | 839 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / March 2, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a leader in the development of highly effective antiviral therapies based on a novel nanomedicine... ► Artikel lesen | |
| 17.02. | NanoViricides, Inc.: NanoViricides Has Filed Quarterly Report for Period Ending December 31, 2020 - Has Sufficient Cash, Coronavirus Drug Candidate Safe in GLP Safety Toxicology Moving Towards IND | 1.732 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / February 17, 2021 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines... ► Artikel lesen | |
| 08.02. | NanoViricides, Inc.: NanoViricides's Broad-Spectrum Antiviral Drug Candidate for the Treatment of COVID-19 Infections was Well Tolerated in GLP and non-GLP Animal Safety Studies | 1.494 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / February 8, 2021 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a global leader in the development of highly effective broad-spectrum antiviral therapies based... ► Artikel lesen |
Seite:
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MAGFORCE | 3,210 | -2,73 % | Hot Stocks heute: ProSiebenSat.1, MagForce und Regeneron | Im heutigen Podcast geht es um den möglichen Übernahmekandidaten ProSiebenSat.1, MagForce und das geplante US-Listing sowie die bevorstehende Zulassung des Prostatakrebsmedikaments. Außerdem wird das... ► Artikel lesen | |
| FORMYCON | 50,60 | -2,32 % | DGAP-News: Formycon AG: Formycon veröffentlicht Halbjahresergebnis 2021 | DGAP-News: Formycon AG
/ Schlagwort(e): Halbjahresbericht/Halbjahresergebnis
Formycon veröffentlicht Halbjahresergebnis 2021
21.09.2021 / 07:30
Für den Inhalt der Mitteilung... ► Artikel lesen | |
| NANOGATE | 0,240 | -5,88 % | Nanogate Aktie - MONTAG WIRD EXPLOSIV! Heftige Kursverläufe erwartet! Das sind die spannenden Gründe! | ||
| ITN NANOVATION | 0,100 | +37,24 % | ItN Nanovation: Gericht eröffnet Insolvenzverfahren | Über das Vermögen der ItN Nanovation AG wurde nun das Insolvenzverfahren eröffnet. Auf Entscheidung des Amtsgerichts in Saarbrücken wurde der bisherige vorläufige Insolvenzverwalter Günter Staab zum... ► Artikel lesen | |
| KOPIN | 4,740 | -1,66 % | Kopin Corp Q2 adjusted earnings Miss Estimates | WASHINGTON (dpa-AFX) - Below are the earnings highlights for Kopin Corp (KOPN):-Earnings: -$3.85 million in Q2 vs. -$1.12 million in the same period last year.
-EPS: -$0.04 in Q2 vs. -$0.01... ► Artikel lesen | |
| NANOLOGICA | 1,375 | -1,43 % | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 04.05.2021 | The following instruments on XETRA do have their first trading 04.05.2021 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag am 04.05.2021
Aktien
1 NO0010895568 Airthings AS
2 ES0105148003... ► Artikel lesen | |
| ONTO INNOVATION | 66,50 | +2,31 % | Onto Innovation (ONTO) Sees Robust Demand for Dragonfly System | ||
| OBDUCAT | 0,183 | 0,00 % | Obducat receives order for an EITRE 3 NIL-system from a leading institute in India | ||
| ACACIA RESEARCH | 6,300 | +7,69 % | ACACIA RESEARCH CORP - 8-K, Current Report | ||
| NVE | 55,50 | +1,83 % | NVE goes ex-dividend tomorrow | ||
| ADVANCE NANOTEK | 2,460 | +8,85 % | ADVANCE NANOTEK LIMITED: Change of Director's Interest Notice - Geoff Acton | ||
| LEHNER INVESTMENTS | 1,000 | 0,00 % | DGAP-Adhoc: LEHNER INVESTMENTS AG: Tochtergesellschaft LEHNER INVESTMENTS ENGINEERING Ltd vereinnahmt Performance Fee in Höhe von EUR 2.460.821,15 | DGAP-Ad-hoc: LEHNER INVESTMENTS AG / Schlagwort(e): Sonstiges
LEHNER INVESTMENTS AG: Tochtergesellschaft LEHNER INVESTMENTS ENGINEERING Ltd vereinnahmt Performance Fee in Höhe von EUR 2.460.821... ► Artikel lesen | |
| NANOFOCUS | 0,900 | 0,00 % | Nanofocus plant eine Kapitalerhöhung | Bei Nanofocus steht eine Sachkapitalerhöhung an. Man will Forderungen der Carl Mahr Holding gegenüber Nanofocus über rund 2,98 Millionen Euro darin einbringen. Dafür soll die Holding entsprechend 2... ► Artikel lesen | |
| RIBER | 1,498 | -0,13 % | Riber: Order for a new production machine in Asia | ||
| DOTZ NANO | 0,242 | -2,42 % | Dotz Nano Limited: Dotz Nano Signs Distribution Agreement with Paraguay's El Alamo SA for Its COVID-19 Diagnostic Test Kits | Melbourne, Australia--(Newsfile Corp. - September 15, 2021) - Dotz Nano Limited (ASX: DTZ) ("Dotz" or the "Company"), an advanced materials company specializing in tracing, authentication and diagnostics... ► Artikel lesen |
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
